IHH Healthcare Bhd ( (IHHHF) ) has released its Q4 earnings. Here is a breakdown of the information IHH Healthcare Bhd presented to its investors.
IHH Healthcare Bhd is a global integrated healthcare provider offering a wide range of services from primary to quaternary care across key markets including Malaysia, Singapore, Türkiye, India, and Greater China. In its latest earnings report, IHH Healthcare reported robust double-digit growth for the fiscal year 2024, driven by increased patient volumes and operational efficiency. The company achieved a 16% increase in revenue and a 17% rise in EBITDA, although its headline PATMI decreased by 10% due to the absence of one-off gains from previous asset disposals. Excluding exceptional items, PATMI rose by 32% year-on-year, reflecting strong core operational performance. The company declared a total ordinary dividend of 10.0 sen per share for FY2024, up from 9.0 sen per share in FY2023. IHH Healthcare’s strategic focus on expanding its capacity and improving patient care was evident with the addition of nearly 1,000 beds and ongoing hospital upgrades. Looking ahead, IHH Healthcare aims to continue its growth trajectory by adding 4,000 new beds over the next four years and leveraging favorable healthcare trends to sustain revenue growth and profitability.